McGovern Announces $836K for UMass Medical to Fight Heart Disease
WORCESTER, MA – Today Congressman Jim McGovern (MA-02) announced that UMass Medical School has been awarded $836,858 by the Department of Health and Human Services (HHS) to support research on treatments and cures for heart and vascular diseases. The new federal funding is awarded through the Community Surveillance of Coronary Heart Disease program, a national HHS effort to invest in medical research at world-class universities like UMass Medical School.
“Heart disease impacts families across the country every year and there has never been a more important time to invest in life-saving medical research. This new federal funding for UMass Medical School will help them continue their cutting-edge medical research that will help save lives while supporting economic growth right here in Massachusetts,” Congressman McGovern said. “I am grateful to HHS Secretary Burwell for making this investment in our community and recognizing UMass Medical School as a leader in the fight against heart disease. Together we can continue to support this important work to help families in Massachusetts and across the country.”
The grant continues the decades-long work of the Worcester Heart Attack Study, funded by the National Heart, Lung and Blood Institute since the mid-1980s. The community-based study provides 40 years of data about the number of heart attacks among residents of the Greater Worcester community and outcomes of their medical care during and after hospitalization. It also provides insights on how patients who experience heart attacks in the community are treated by physicians.
“We’re going to have a 40-year picture of heart disease, which is unique. What we’ve learned since 1975 is that even though Worcester heart attack patients have become older and sicker, often having multiple diseases, the incidence of heart attacks is declining, and patients’ prognosis both in-hospital and post-discharge is getting better,” said Robert Goldberg, PhD, professor of quantitative health sciences and founder and principal investigator of the renamed Worcester Heart Attack Study. “We think this is because patients are being much more aggressively managed with evidence-based care.
“What we want to learn is will these trajectories continue: will incidence of heart attacks continue to decrease? Will patients’ prognosis continue to improve? And how much more effectively can patients be managed?”
The new funding will help Dr. Goldberg and his research team achieve these goals by monitoring trends of heart attack patients; and patient management .
“Most novel is that we’re going to use bioinformatics and very technical approaches to sift through available medical records, be they in paper or electronic form, and see how machines do compared to our manual abstractors,” Goldberg said. “The goal is to streamline the approach to data collection and data abstraction and give feedback to investigators and clinicians in real time.”